Clinical trials
Recruiting Phase 1/2 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 9 |
| 2022 | 9 |
| 2023 | 16 |
| 2024 | 14 |
| 2025 | 30 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 18 |
| Merck Sharp & Dohme LLC | 9 |
| GlaxoSmithKline | 8 |
| Bristol-Myers Squibb | 6 |
| Daiichi Sankyo | 5 |
| AbbVie | 4 |
| Novartis Pharmaceuticals | 4 |
| Pfizer | 4 |
| Astellas Pharma Global Development, Inc. | 3 |
| Regeneron Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 16 |
| Neoplasms | 12 |
| Breast Neoplasms | 11 |
| Endometrial Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Colorectal Neoplasms | 7 |
| Multiple Myeloma | 6 |
| Prostatic Neoplasms | 6 |
| Recurrence | 6 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.